Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported